Synthesis, structure, and conformation of anti-tumor agents in the solid and solution states: Hydroxyl derivatives of ftorafur

Nucleosides, Nucleotides and Nucleic Acids

Volumn 21, Issue 11-12, 2002, Pages 863-882

  Stokes, David M ^a   Paul, Brajeswar ^b   Alderfer, James L ^a   Wollman, Robert M ^a   Srikrishnan, Thamarapu ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' HYDROXYFTORAFUR; 2',3' DIHYDROXYFTORAFUR; 3' HYDROXYFTORAFUR; ANTINEOPLASTIC AGENT; FLUOROURACIL; TEGAFUR; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ANISOTROPY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONFORMATION; CORRELATION ANALYSIS; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG CONFORMATION; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; HYDROGEN BOND; MELTING POINT; MOLECULAR INTERACTION; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR OVERHAUSER EFFECT; REDUCTION; SOLID STATE; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

ANTIMETABOLITES, ANTINEOPLASTIC; CRYSTALLOGRAPHY, X-RAY; HYDROXYL RADICAL; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; SOLUTIONS; TEGAFUR;

ANIMALIA;

EID: 0036913339     PISSN: 15257770     EISSN: None     Source Type: Journal    
DOI: 10.1081/NCN-120016611     Document Type: Article

References (24)

1. Blokhina, N.G.; Vozny, E.K.; Garin, A.M. Results of treatment of malignant tumors with ftorafur. Cancer 1972, 30, 390-392.
2. Karev, N.I.; Blokhina, N.G.; Vozhy, E.K.; Pershin, M.P. Experience with ftorafur treatment in breast cancer. Neoplasma. 1972, 19, 347-350.
3. 1-2′-furanidyl-5-fluorouraci). Cancer Res. 1976, 36, 1821-1824.
4. Cohen, A.M. The disposition of ftorafur in rats after intravenous administration. Drug Metab. Dispos. 1975, 3, 303-308.
5. 1-2′-tetrahydrofuryl)-5-fluorouracil and 5-fluorouracul on nucleic acid and protein biosyntheses in ehrlich ascites cells. Cancer Research. 1976, 36, 33-36.
6. Smolyanskaya, A.Z.; Tugarinov, O.A. To biological activity of antitumour antimetabolite "ftorafur". Neoplasma 1972, 19, 341-345.
7. Lin, A. J.; Benjamin, R.S.; Rao, P.N.; Loo, T.L. Synthesis and Biological Activities of Ftorafur Metabolites. 3′- and 4′-Hydroxyftorafur. J. Med. Chem. 1979, 22, 1096-1100.
8. Wu, A.T.; Au, J.L.; Sadee, W. Hydroxylated Metabolites of R,S-1-(Tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in Rats and Rabbits. Cancer Res. 1978, 38, 210-214.
9. Au, J.L.; Wu, A.T.; Friedman, M.A.; Sadee, W. Pharmacokinetics and metabolism of ftorafur in man. Cancer Treatment Report 1979, 63, 343-350.
10. Meyer Jr, R.B.; Levenson, C.H. Structure of two hydroxylated metabolites of ftorafur. Biochemical Pharmacology 1980, 29, 665-668.
11. Benvenuto, J.A.; Lu, K.; Hall, S.W.; Benjamin, R.S.; Loo, T.L. Disposition and metabolism of 1-(tetrahydro-2-furanyl)-5-fluorouracil (ftorafur) in humans. Cancer Res. 1978, 38, 3867-3870.
12. Horwitz, J.P.; McCormick, J.J.; Philips, K.D.; Maher, V.M.; Otto, J.R.; Kessel, D.; Zemlicka, In vitro biological evaluation of the R and S isomers of 1-(Tetrahydrofuran-2-y1) 5-flurouracil. J. Cancer Res. 1975, 35, 1301-1304.
13. Wu, A.T.; Schwandt, H.-J.; Finn, C.; Sadee, W. Determination of ftorafur and 5-fluorouracil levels in plasma and urine. Res. Comm. Chem. Path. Pharmacol. 1970, 14, 89-102.
14. Benvenuto, J.A.; Farquhar, D.; Freireich, E.J.; Loo, T.L. Biotransformation of ftorafur (Ft, NSC-148958) in man. Proc. Amer. Assoc. Cancer Res. 1977, 18, 145.
15. Johnson, R.K.; Garibjanian, B.T.; Houchens, D.P.; Kline, I.; Gaston, M.R.; Syrkin, A.B.; Goldin, A. Comparison of 5-fluorouracil and ftorafur. 1. Quantitative and qualitative differences in toxicity to mice. Cancer Treat. Report 1976, 60, 1335-1345.
16. Garibjanian, B.T.; Johnson, R.K.; Kline, I.; Vadlamudi, S.; Gang, M.; Vensitti, J.M.; Goldin, A. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors. Cancer Treat. Report 1976, 60, 1347-1361.
17. Perlin, A.S. Tetroses. Methods in Carbohydrate Chemistry 1962, 1, 64-66.
18. Anderson, R.; Theander, O.; Westerlund, E. Studies on D-erythrose and its acetates. Carbohydrate Res. 1978, 61, 501-509.
19. Hampton, A.; Nichol, A.W.; Nucleotides. V. Purine ribonucleotide 2′,3′-cyclic carbonates. Preparation and use for the synthesis of 5′-monosubstitued nucleotides. Biochemistry 1966, 5, 2076-2082.
20. Holy, A. Synthesis of 1-[3-deoxy-β-D-psicofuranosyl]uracil and related compounds. Nucleic Acid Res. 1974, 1, 289-294.
21. Nakai, Y.; Yamamoto, K.; Terada, K.; Uchida, T.; Shimizu, N.; Nishigaki, S. The crystal structure of ftorafur. Chem. Pharm. Bull. (Japan) 1982, 30, 2629-2632.
22. Germain, G.; Main, P.; Woolfson, M.M. The application of phase relationships to complex structures. III. The optimum use of phase relationships. Acta Cryst. 1971, A27, 368-376.
23. Enraf-Nonius: Structure Determination Package, Enraf-Nonius, Delft.
24. Johnson, C.K. "ORTEP Report ORNL-3794", Oak Ridge National Laboratory, Tennessee, 1965.